NCT03151239View on ClinicalTrials.gov

"Effect of Nicotinamide Mononucleotide (NMN) on Cardiometabolic Function"

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

May 30, 2019

Study Completion Date

June 30, 2021

Conditions
Glucose Metabolism Disorders
Interventions
DIETARY_SUPPLEMENT

NMN supplement

Intervention will last at least 8 weeks in the form of two capsules (250 mg total).

OTHER

Placebo

Intervention will last at least 8 weeks in the form of two capsules.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03151239 - "Effect of Nicotinamide Mononucleotide (NMN) on Cardiometabolic Function" | Biotech Hunter | Biotech Hunter